NRG Therapeutics

Stevenage, United Kingdom · Founded 2018 · Privately Held (backing)

Developer of a drug discovery platform intended to develop therapeutic approaches to restore mitochondrial function. NRG Therapeutics is based in Stevenage, United Kingdom and was founded in 2018. Its last reported valuation was $51.9 million in Sep 2025. It has raised $95 million.

Last reported valuation
$51.9M
Oct 2026
Priced at
—
Total raised
$95.0M
Last round
—

Who backs NRG Therapeutics?

17 investors
InvestorType
Innovate UKOther
British Business BankOther
M VenturesVenture capital
SV Health InvestorsVenture capital
Novartis Venture FundOther
Omega FundsPE / buyout
Brandon CapitalVenture capital
Caixa Capital RiscOther
Arthur Roach—
Brandon Biocatalyst—
+ 7 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

NRG Therapeutics investors

17 investors are on record for NRG Therapeutics, including Innovate UK, British Business Bank, M Ventures and SV Health Investors.

Free account
More of NRG Therapeutics with a free account
  • ·The complete investor list: 17 names
  • ·Watch NRG Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 17 firms already write checks for companies like NRG Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View